Makes use of recombinant DNA technology, uses bacterial, yeast, plant or animal cells in the production of relevant microbial protective protein antigen used in vaccine preparation, makes use of synthetic peptides and oligonucleotides to form part of the antigen molecule where the antibody will attach itself (epitope of the pathogen) to elicit an immune response